Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › BOSTON › BRIGHAM & WOMENS HOSPITAL, INC.

BRIGHAM & WOMENS HOSPITAL, INC.

NPI: 1790717650 · BOSTON, MA 02115 · General Acute Care Hospital · NPI assigned 07/07/2006

$252.58M
Total Medicaid Paid
6,310,608
Total Claims
5,467,192
Beneficiaries
943
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMORASH, DANIEL (CFO)
NPI Enumeration Date07/07/2006

Related Entities

Other providers sharing the same authorized official: MORASH, DANIEL

ProviderCityStateTotal Paid
BRIGHAM & WOMENS PHYSICIANS ORGANIZATION INC BOSTON MA $43.38M
BRIGHAM & WOMEN'S PHYSICIANS ORGANIZATION INC MILFORD MA $755.61

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 913,441 $38.41M
2019 905,474 $35.73M
2020 789,315 $33.84M
2021 1,109,358 $45.60M
2022 1,129,645 $51.03M
2023 848,011 $27.95M
2024 615,364 $20.02M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 372,174 313,004 $47.32M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 148,331 125,230 $13.69M
J2350 Injection, ocrelizumab, 1 mg 1,223 1,064 $8.60M
96361 Intravenous infusion, hydration; each additional hour 23,167 20,604 $8.58M
99283 Emergency department visit for the evaluation and management, moderate severity 49,924 45,721 $7.04M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 22,689 19,131 $6.86M
99284 Emergency department visit for the evaluation and management, high severity 39,413 36,170 $5.75M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 278,056 219,901 $5.45M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 25,930 23,352 $4.75M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 73,136 64,424 $4.08M
G0378 Hospital observation service, per hour 27,861 20,914 $3.84M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 13,938 13,288 $3.70M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 63,354 28,043 $3.37M
J1745 Injection, infliximab, excludes biosimilar, 10 mg 3,136 1,672 $2.97M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 5,014 4,885 $2.77M
74177 Computed tomography, abdomen and pelvis; with contrast material 21,107 20,003 $2.56M
90834 Psychotherapy, 45 minutes with patient 41,592 24,358 $2.56M
45380 Colonoscopy, flexible; with biopsy, single or multiple 4,395 4,272 $2.50M
J3380 Injection, vedolizumab, intravenous, 1 mg 1,317 1,074 $2.39M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 48,692 47,250 $2.20M
J2323 Injection, natalizumab, 1 mg 906 824 $2.13M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 13,974 13,338 $2.02M
59025 Fetal non-stress test 7,873 4,830 $1.94M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 7,944 6,787 $1.84M
J3490 Unclassified drugs 25,371 18,354 $1.66M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 8,302 7,014 $1.61M
78815 Positron emission tomography (PET) for limited area imaging 1,941 1,854 $1.53M
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 17,106 14,241 $1.52M
J2357 Injection, omalizumab, 5 mg 2,622 1,816 $1.50M
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg 1,462 971 $1.43M
70450 Computed tomography, head or brain; without contrast material 12,087 11,097 $1.37M
77063 Screening digital breast tomosynthesis, bilateral 19,800 19,546 $1.28M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 48,954 46,950 $1.24M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 48,981 46,974 $1.24M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 8,684 8,451 $1.23M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 2,085 2,035 $1.23M
S9485 Crisis intervention mental health services, per diem 2,012 1,439 $1.18M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 8,319 7,787 $1.16M
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 11,008 10,673 $1.16M
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg 1,014 985 $1.16M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 29,477 25,936 $1.15M
74183 4,811 4,620 $1.07M
76830 Ultrasound, transvaginal 10,807 10,392 $1.02M
71275 Computed tomographic angiography, chest, with contrast material 6,310 5,956 $1.01M
76801 9,783 8,801 $966K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 55,380 48,311 $875K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 6,648 6,459 $842K
76819 Fetal biophysical profile; without non-stress testing 11,453 7,373 $825K
96375 Therapeutic injection; each additional sequential IV push 24,132 20,863 $825K
71046 Radiologic examination, chest; 2 views 40,870 37,383 $801K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 190,955 159,931 $789K
96415 2,913 2,448 $782K
J0585 Injection, onabotulinumtoxina, 1 unit 2,388 1,749 $774K
97161 13,316 12,802 $754K
J0485 Injection, belatacept, 1 mg 2,192 1,124 $750K
93308 4,282 4,010 $728K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 5,435 5,272 $714K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies 592 567 $700K
20610 5,868 5,387 $695K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 21,361 18,054 $693K
71260 Computed tomography, thorax, diagnostic; with contrast material 8,308 7,960 $681K
77300 2,414 2,017 $661K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 3,419 3,192 $651K
D1110 Prophylaxis - adult 19,757 14,774 $646K
99215 Prolong outpt/office vis 5,922 5,564 $637K
72197 2,827 2,712 $636K
76700 Ultrasound, abdominal, real time with image documentation; complete 4,852 4,717 $630K
76642 7,125 6,268 $623K
62323 1,730 1,692 $623K
84443 Thyroid stimulating hormone (TSH) 69,454 66,899 $617K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 38,740 37,613 $616K
93971 4,250 4,059 $615K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 1,023 984 $615K
D9450 48,440 30,078 $612K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 23,014 18,381 $610K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 25,885 11,982 $607K
86481 11,306 10,881 $604K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4,905 4,598 $595K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 9,953 8,859 $594K
87631 7,596 7,201 $593K
71250 9,691 9,305 $588K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 10,549 9,586 $568K
92551 10,598 9,350 $565K
93970 3,155 3,021 $555K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 33,039 32,070 $553K
43235 885 859 $537K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 11,447 10,958 $535K
11102 1,282 1,228 $535K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 10,638 9,687 $517K
70551 Magnetic resonance imaging, brain; without contrast material 3,153 3,014 $507K
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 824 339 $497K
36561 473 452 $493K
58300 1,897 1,846 $488K
83036 Hemoglobin; glycosylated (A1C) 98,871 96,199 $477K
70496 2,415 2,303 $476K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 9,336 8,890 $470K
76813 5,644 5,519 $468K
76536 5,086 4,962 $461K
J9312 Injection, rituximab, 10 mg 285 255 $454K
88305 Level IV - Surgical pathology, gross and microscopic examination 37,438 25,022 $418K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 3,268 3,063 $411K
76705 Ultrasound, abdominal, real time with image documentation; limited 4,264 4,012 $410K
11900 2,237 2,125 $404K
D2751 Crown - porcelain fused to predominantly base metal 871 649 $403K
72141 3,027 2,920 $401K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 7,909 7,153 $388K
99201 3,224 3,087 $386K
90837 Psychotherapy, 53 minutes with patient 7,519 4,730 $385K
90651 3,620 3,594 $385K
90686 29,153 28,746 $379K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 53,313 52,005 $379K
74176 Computed tomography, abdomen and pelvis; without contrast material 3,338 3,166 $377K
70544 2,512 2,384 $377K
77386 1,017 105 $375K
11104 762 727 $375K
81513 5,897 5,478 $375K
76770 2,910 2,824 $370K
D0120 Periodic oral evaluation - established patient 21,929 17,419 $370K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 15,957 15,165 $369K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 18,743 16,842 $366K
77334 2,108 1,753 $365K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 4,525 4,066 $363K
93017 5,297 5,103 $359K
77080 7,084 7,005 $356K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 15,485 15,121 $355K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 16,219 15,909 $347K
64493 708 670 $341K
17110 2,070 1,959 $329K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 3,269 3,204 $327K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 5,783 4,831 $320K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 1,377 1,287 $315K
ATP15 40,826 31,381 $312K
83880 17,272 15,680 $311K
58100 1,132 1,095 $306K
82728 37,410 36,142 $306K
77301 945 788 $305K
83735 85,543 63,452 $302K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 7,393 3,960 $301K
78451 1,105 1,071 $298K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 72,973 64,160 $292K
57454 962 913 $292K
86780 28,168 27,404 $290K
84702 22,170 18,197 $289K
85027 81,529 70,478 $289K
D1120 Prophylaxis - child 5,663 5,604 $284K
73221 1,788 1,687 $283K
76820 7,296 4,311 $281K
ATP08 45,322 35,927 $260K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 8,054 7,352 $259K
58301 1,196 1,155 $258K
90715 11,742 11,507 $255K
97802 3,966 3,829 $251K
84484 27,790 23,247 $246K
86803 27,261 26,519 $246K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 3,915 2,986 $246K
D0274 Bitewings - four radiographic images 9,916 7,806 $245K
97803 4,181 3,750 $244K
94010 5,914 5,554 $237K
80048 Basic metabolic panel (calcium, ionized) 192,435 155,329 $235K
86850 32,968 30,166 $233K
20553 1,783 1,702 $230K
J2182 Injection, mepolizumab, 1 mg 271 235 $223K
77062 2,465 2,412 $221K
90832 Psychotherapy, 30 minutes with patient 7,650 6,317 $221K
99173 11,741 11,210 $219K
87086 Culture, bacterial; quantitative colony count, urine 41,577 38,096 $218K
19083 283 278 $218K
71045 Radiologic examination, chest; single view 10,328 8,811 $216K
83970 14,120 13,541 $214K
82607 27,434 26,639 $209K
77067 Screening mammography, bilateral, including computer-aided detection 19,882 19,628 $208K
96110 Developmental screening, with scoring and documentation, per standardized instrument 22,149 19,514 $208K
97165 2,754 2,589 $206K
Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg 68 55 $203K
0001A 6,659 6,215 $198K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 708 678 $197K
D2392 Resin-based composite - two surfaces, posterior, primary or permanent 3,652 2,095 $197K
ATP14 25,713 22,195 $180K
10005 572 548 $180K
0002A 5,736 5,351 $178K
D2391 Resin-based composite - one surface, posterior, primary or permanent 4,090 2,184 $172K
81025 31,040 29,000 $170K
72156 1,843 1,748 $170K
76882 1,809 1,655 $166K
77470 715 671 $164K
87632 1,605 1,529 $161K
77065 Tomosynthesis, mammo 3,802 3,558 $161K
70491 1,367 1,314 $156K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) 17,763 17,663 $155K
J1200 Injection, diphenhydramine hcl, up to 50 mg 5,435 4,408 $153K
72158 1,303 1,235 $149K
77061 1,444 1,425 $148K
D7140 Extraction, erupted tooth or exposed root 3,161 1,283 $148K
87536 3,647 3,497 $147K
83690 32,110 28,954 $146K
J1050 Injection, medroxyprogesterone acetate, 1 mg 2,870 2,825 $146K
90750 2,288 2,272 $145K
93296 5,015 4,924 $142K
90791 Psychiatric diagnostic evaluation 2,049 1,980 $141K
73030 7,352 6,682 $139K
83605 17,916 15,369 $137K
73630 8,662 7,531 $136K
74246 909 895 $134K
83550 28,149 27,225 $133K
87481 5,839 5,443 $131K
88307 2,017 1,646 $127K
81001 72,039 64,211 $124K
86141 20,282 18,223 $123K
97530 Therapeutic activities, direct patient contact, each 15 minutes 2,463 1,624 $123K
10060 712 685 $123K
11100 507 468 $123K
D0140 Limited oral evaluation - problem focused 4,577 3,020 $122K
80076 93,281 79,626 $120K
85610 55,166 41,881 $118K
11056 1,377 1,272 $117K
73610 6,720 5,958 $116K
73564 7,047 6,196 $115K
D2150 Silver amalgam - two surfaces, primary or permanent 2,287 1,122 $113K
87340 14,956 14,501 $112K
88341 2,687 2,543 $111K
95886 590 569 $110K
77336 1,683 856 $110K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 135 134 $108K
86235 2,855 2,769 $108K
87077 18,854 17,777 $108K
97162 2,266 2,155 $107K
73502 6,392 5,994 $107K
17000 1,325 1,286 $106K
D1206 Topical application of fluoride varnish 3,941 3,906 $105K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 8,404 7,308 $104K
73130 6,683 5,314 $104K
83540 28,959 27,987 $102K
91065 633 603 $102K
72100 5,308 5,171 $101K
82784 11,079 10,537 $101K
82803 6,659 5,568 $100K
77290 189 172 $98K
82746 12,222 11,896 $97K
80050 General health panel 6,482 6,311 $96K
D0210 Intraoral - complete series of radiographic images 2,432 1,700 $96K
73562 6,439 5,631 $95K
78431 221 214 $95K
J1650 Injection, enoxaparin sodium, 10 mg 6,538 2,943 $95K
86762 8,403 8,165 $95K
ATP03 31,074 26,532 $95K
88342 5,106 4,869 $94K
77002 2,488 2,311 $93K
86003 2,128 2,076 $90K
J7999 Compounded drug, not otherwise classified 7,711 5,125 $89K
86900 33,467 30,620 $89K
95117 4,185 2,479 $88K
72157 1,620 1,544 $88K
77295 171 166 $87K
0124A 3,420 3,340 $87K
72125 Computed tomography, cervical spine; without contrast material 3,384 3,136 $87K
92587 452 441 $85K
70498 1,829 1,736 $82K
84439 16,954 16,163 $82K
87070 14,744 13,660 $82K
ATP17 11,566 10,067 $82K
74178 595 581 $81K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 3,261 2,830 $81K
87088 15,016 14,163 $81K
91200 1,091 1,070 $81K
77338 1,075 859 $80K
94060 1,428 1,346 $78K
90460 Immunization administration through 18 years of age via any route, first or only component 9,198 9,068 $77K
87081 19,633 18,372 $77K
11981 268 260 $76K
88185 384 354 $74K
86901 33,275 30,442 $74K
D1208 Topical application of fluoride, excluding varnish 2,554 2,538 $74K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 986 686 $73K
J1644 Injection, heparin sodium, per 1000 units 10,519 5,463 $72K
99385 1,007 986 $72K
ATP11 12,249 10,613 $72K
70486 1,126 1,058 $70K
ATP16 9,041 6,447 $70K
64615 369 363 $69K
G0105 Colorectal cancer screening; colonoscopy on individual at high risk 89 88 $68K
82570 33,537 30,251 $68K
76942 1,025 970 $67K
87040 6,087 5,077 $67K
80053 Comprehensive metabolic panel 83,591 73,899 $66K
J3010 Injection, fentanyl citrate, 0.1 mg 35,133 29,649 $66K
94726 1,610 1,539 $65K
J9310 Injection, rituximab, 100 mg 102 88 $64K
84146 5,237 4,965 $64K
74174 1,167 1,101 $64K
86787 6,410 6,194 $64K
82670 3,474 3,044 $62K
87799 6,622 4,617 $62K
0004A 2,630 2,446 $61K
88173 958 915 $61K
99381 795 788 $61K
84403 4,267 4,128 $60K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 5,833 5,585 $60K
62370 1,853 1,687 $60K
95885 320 308 $60K
87186 12,438 11,663 $59K
84153 6,323 6,126 $59K
96367 490 440 $59K
J2405 Injection, ondansetron hydrochloride, per 1 mg 31,193 25,631 $59K
86355 4,468 4,253 $59K
93321 714 688 $58K
J9999 Not otherwise classified, antineoplastic drugs 2,216 1,477 $57K
ATP18 8,099 6,924 $57K
83001 4,746 4,541 $56K
73110 3,549 3,039 $56K
77001 1,385 1,319 $56K
77066 Tomosynthesis, mammo 3,814 3,717 $56K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results 1,274 1,071 $56K
76775 684 662 $56K
87653 1,959 1,927 $55K
81003 38,128 34,323 $55K
99281 Emergency department visit for the evaluation and management, self-limited or minor 423 392 $55K
86706 8,159 7,835 $53K
87522 Neg quan hep c or qual rna 2,419 2,290 $52K
D2331 1,251 571 $52K
85730 9,912 8,732 $52K
83516 5,927 5,644 $51K
92610 403 379 $51K
82043 24,418 23,591 $50K
86140 19,273 18,025 $49K
90847 Family psychotherapy with the patient present, 50 minutes 540 322 $49K
84425 4,125 4,039 $48K
86360 2,670 2,571 $48K
D0150 Comprehensive oral evaluation - new or established patient 2,146 1,597 $48K
85379 7,283 6,900 $48K
J7050 Infusion, normal saline solution, 250 cc 23,852 17,702 $47K
D0220 Intraoral - periapical first radiographic image 4,729 3,083 $47K
73560 3,177 2,799 $47K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 3,023 2,868 $47K
11982 241 238 $47K
76937 1,944 1,833 $47K
73080 1,866 1,717 $46K
94729 2,331 2,238 $46K
90677 2,039 1,994 $46K
75574 390 383 $45K
93325 1,181 1,127 $45K
86160 3,974 3,805 $45K
J2250 Injection, midazolam hydrochloride, per 1 mg 29,239 25,295 $45K
76857 708 635 $45K
64483 132 125 $44K
J1170 Injection, hydromorphone, up to 4 mg 14,303 9,846 $43K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials 3,541 2,059 $43K
80061 Lipid panel 83,173 80,785 $43K
76604 538 508 $42K
99496 675 647 $42K
74018 1,328 1,178 $42K
72040 2,036 1,968 $41K
J1885 Injection, ketorolac tromethamine, per 15 mg 17,787 14,740 $41K
85652 29,975 27,746 $40K
86038 6,114 5,939 $40K
90746 1,832 1,806 $39K
83520 4,358 4,069 $39K
90853 Group psychotherapy (other than of a multiple-family group) 2,079 980 $39K
83021 2,320 2,261 $38K
86359 2,672 2,574 $38K
99386 651 629 $38K
86832 572 541 $38K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 938 894 $38K
80197 13,502 8,643 $37K
90472 Immunization administration, each additional vaccine (list separately) 12,911 12,735 $37K
D1351 Sealant - per tooth 1,015 404 $37K
83655 3,474 3,433 $37K
99205 Prolong outpt/office vis 226 221 $37K
0054A 1,830 1,704 $37K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,598 1,535 $36K
90732 2,613 2,551 $35K
84402 2,390 2,315 $35K
J2704 Injection, propofol, 10 mg 25,393 21,670 $34K
87497 3,786 2,689 $34K
87184 7,981 7,518 $34K
86357 2,245 2,162 $34K
0071A 786 754 $34K
94621 303 290 $33K
76870 332 314 $33K
ATP07 5,627 4,916 $33K
86833 541 514 $32K
J3475 Injection, magnesium sulfate, per 500 mg 9,492 8,240 $32K
86334 3,859 3,711 $32K
86704 4,657 4,480 $32K
95816 156 150 $31K
J0696 Injection, ceftriaxone sodium, per 250 mg 6,423 5,228 $31K
ATP09 5,569 4,161 $31K
J2791 Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu 138 125 $31K
72146 875 829 $31K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 312 265 $30K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 3,962 3,192 $30K
93975 321 310 $30K
86147 1,138 1,098 $30K
86765 3,473 3,351 $30K
D0272 Bitewings - two radiographic images 1,089 1,028 $30K
83002 2,428 2,173 $29K
72170 1,559 1,485 $29K
88304 1,614 1,464 $29K
70548 176 169 $28K
73552 1,340 1,219 $28K
86225 4,269 4,107 $28K
86769 1,282 1,247 $27K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 1,705 1,673 $27K
93880 435 423 $26K
20550 173 153 $26K
73700 535 504 $25K
84590 3,874 3,779 $25K
88360 478 460 $25K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 181 161 $25K
84480 2,982 2,825 $25K
90662 8,001 7,841 $25K
87338 2,823 2,768 $24K
20552 193 185 $24K
91320 1,725 1,697 $24K
Q0139 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis) 62 42 $24K
90670 5,734 5,638 $24K
99443 4,447 4,269 $24K
83020 2,244 2,133 $23K
D2160 495 280 $23K
75561 116 112 $23K
84156 14,463 11,798 $23K
49083 73 37 $23K
82950 5,407 5,338 $22K
73140 964 890 $22K
86618 2,229 2,156 $22K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 80 52 $22K
90480 2,259 2,230 $22K
90714 891 886 $22K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 42,619 39,433 $21K
72070 738 709 $21K
99495 544 526 $21K
71271 881 874 $21K
0072A 461 460 $21K
87517 1,079 1,039 $21K
86677 1,988 1,950 $21K
D2140 570 322 $20K
82330 3,107 2,438 $20K
Q3014 Telehealth originating site facility fee 13,432 12,415 $20K
ATP10 3,844 3,261 $20K
A9585 Injection, gadobutrol, 0.1 ml 26,979 25,379 $20K
82533 2,301 2,058 $19K
D2393 Resin-based composite - three surfaces, posterior, primary or permanent 469 253 $19K
19081 28 27 $19K
99397 927 827 $19K
86923 1,283 1,030 $19K
73590 2,077 1,850 $19K
96409 36 35 $19K
72131 635 592 $19K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 11,642 10,458 $18K
J0690 Injection, cefazolin sodium, 500 mg 9,670 8,312 $18K
96900 433 60 $18K
84165 4,533 4,335 $18K
ATP23 1,992 1,375 $18K
87625 992 967 $18K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 914 853 $18K
87102 3,415 3,235 $18K
80179 1,425 1,338 $17K
64494 563 536 $17K
88108 661 644 $17K
J1756 Injection, iron sucrose, 1 mg 409 250 $17K
86708 2,581 2,488 $16K
93976 174 167 $16K
84100 35,003 25,881 $16K
86200 2,357 2,301 $16K
94664 487 461 $16K
86735 1,926 1,846 $15K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 4,845 2,676 $15K
82088 778 739 $15K
82105 1,879 1,829 $15K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 169 167 $15K
73060 427 379 $14K
82785 1,637 1,587 $14K
99188 1,139 1,119 $14K
86376 1,472 1,423 $14K
82024 664 636 $14K
82627 849 829 $14K
90691 590 579 $13K
29581 142 61 $13K
87529 569 551 $13K
88184 493 457 $13K
87210 4,951 3,320 $13K
90696 866 861 $13K
83993 1,188 1,149 $13K
0031A 405 349 $13K
86146 814 791 $13K
86255 1,740 1,558 $13K
81229 13 12 $12K
70543 40 38 $12K
85045 6,468 5,120 $12K
ATP04 2,197 1,889 $12K
90734 2,468 2,458 $12K
J0248 Injection, remdesivir, 1 mg 31 17 $12K
82610 3,135 2,838 $12K
64450 58 50 $12K
87252 595 558 $11K
95076 12 12 $11K
86431 3,769 3,680 $11K
80299 982 856 $11K
G0008 Administration of influenza virus vaccine 11,182 11,060 $11K
J3370 Injection, vancomycin hcl, 500 mg 2,872 1,929 $11K
96376 7,136 5,934 $11K
90461 3,383 3,347 $11K
87106 1,468 1,405 $11K
36415 Collection of venous blood by venipuncture 131,369 108,738 $11K
87400 747 730 $11K
J1726 Injection, hydroxyprogesterone caproate, (makena), 10 mg 217 76 $11K
88112 370 351 $11K
C1769 Guide wire 2,760 2,552 $11K
93923 186 181 $11K
77081 448 442 $11K
11901 70 69 $11K
11721 459 429 $11K
0051A 287 287 $10K
80143 1,321 1,234 $10K
87205 4,452 3,961 $10K
87177 2,044 1,743 $10K
84134 1,805 1,420 $10K
83921 1,178 1,160 $10K
80164 1,836 1,655 $10K
87046 1,640 1,563 $10K
81450 111 104 $10K
82550 8,970 7,988 $10K
0081A 224 224 $10K
87209 1,043 872 $9K
86800 1,105 1,072 $9K
J1030 Injection, methylprednisolone acetate, 40 mg 5,274 5,029 $9K
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 2,293 2,230 $9K
ATP12 1,449 1,241 $9K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 454 449 $9K
D0330 Panoramic radiographic image 227 153 $9K
82274 1,208 1,180 $9K
84244 838 800 $9K
87045 1,593 1,522 $8K
73523 741 695 $8K
88313 361 352 $8K
J3262 Injection, tocilizumab, 1 mg 53 36 $8K
90716 1,509 1,499 $8K
D2330 227 104 $8K
77332 79 66 $8K
82565 9,137 8,533 $8K
J2270 Injection, morphine sulfate, up to 10 mg 7,192 5,973 $8K
83721 2,379 2,311 $8K
92083 214 202 $8K
97116 351 238 $8K
80175 1,747 1,634 $8K
82951 658 650 $8K
95913 88 83 $8K
90792 Psychiatric diagnostic evaluation with medical services 887 872 $8K
87324 1,433 1,350 $7K
80177 1,334 1,240 $7K
64650 24 24 $7K
J7300 Intrauterine copper contraceptive (paragard) 129 127 $7K
0154A 211 204 $7K
20605 53 50 $7K
J7120 Ringers lactate infusion, up to 1000 cc 4,453 4,072 $7K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 2,858 2,639 $7K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 9,054 8,233 $7K
83615 6,991 5,358 $7K
76376 646 617 $7K
78264 38 38 $7K
73720 31 29 $7K
84445 181 177 $7K
ATP05 1,088 954 $7K
0082A 147 145 $7K
90707 1,685 1,673 $7K
J3489 Injection, zoledronic acid, 1 mg 205 192 $7K
72195 53 52 $6K
85007 3,598 2,870 $6K
93299 169 166 $6K
93298 288 282 $6K
84144 421 314 $6K
86039 1,021 1,002 $6K
94618 161 161 $6K
84550 8,958 8,072 $6K
82010 1,185 1,043 $6K
D0145 Oral evaluation for a patient under three years of age 227 224 $6K
G0127 Trimming of dystrophic nails, any number 2,968 2,799 $6K
85613 1,018 981 $6K
74221 51 51 $6K
90656 625 595 $6K
84630 631 618 $6K
86694 538 515 $6K
58558 13 12 $6K
ATP02 1,445 1,230 $6K
J2060 Injection, lorazepam, 2 mg 4,097 3,112 $6K
85597 535 522 $5K
90632 314 301 $5K
86665 318 294 $5K
85018 2,744 2,708 $5K
84432 643 623 $5K
69209 43 39 $5K
87641 206 198 $5K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 19 17 $5K
S0020 Injection, bupivicaine hydrochloride, 30 ml 269 246 $5K
C7900 Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service 731 538 $5K
84681 462 438 $5K
86828 459 435 $5K
83718 798 786 $5K
87116 868 760 $5K
93356 1,471 1,413 $5K
87075 1,023 948 $5K
0064A 217 207 $4K
0012A 207 200 $4K
57456 14 13 $4K
86580 628 599 $4K
85384 773 622 $4K
10061 28 26 $4K
J0171 Injection, adrenalin, epinephrine, 0.1 mg 654 570 $4K
J2795 Injection, ropivacaine hydrochloride, 1 mg 3,257 2,964 $4K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 1,164 1,006 $4K
85014 2,032 1,989 $4K
97166 51 51 $4K
88312 521 500 $4K
86162 390 380 $4K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 28,218 24,059 $4K
83519 441 423 $4K
84305 357 345 $4K
83525 567 557 $4K
J0780 Injection, prochlorperazine, up to 10 mg 1,023 788 $4K
M0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring 95 89 $4K
86352 105 96 $4K
99153 Mod sedat endo service >5yrs 7,868 7,374 $4K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 39 37 $4K
C7901 Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service 2,951 1,761 $4K
80074 106 102 $4K
81206 260 241 $4K
73090 326 294 $4K
86356 439 425 $4K
0011A 211 203 $4K
89051 1,192 1,030 $4K
J0692 Injection, cefepime hydrochloride, 500 mg 512 336 $3K
86644 433 400 $3K
96127 336 324 $3K
0003A 181 180 $3K
86870 240 209 $3K
84132 4,253 3,835 $3K
ATP19 471 367 $3K
88346 152 146 $3K
0074A 80 80 $3K
90682 170 163 $3K
ATP13 376 350 $3K
88350 61 60 $3K
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 14,436 13,709 $3K
82947 2,832 2,527 $3K
87015 848 743 $3K
D0270 374 230 $3K
0052A 62 62 $3K
86682 436 417 $3K
80178 920 838 $3K
83498 130 127 $3K
D0230 Intraoral - periapical each additional radiographic image 446 219 $3K
87206 882 772 $2K
82150 577 524 $2K
77370 19 13 $2K
99152 5,751 5,334 $2K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 2,062 1,954 $2K
72110 192 190 $2K
J1020 Injection, methylprednisolone acetate, 20 mg 2,784 2,644 $2K
99442 884 852 $2K
89343 65 62 $2K
93225 52 52 $2K
83930 707 635 $2K
82390 363 352 $2K
84300 1,107 978 $2K
82952 657 649 $2K
98940 368 193 $2K
87150 186 178 $2K
J7030 Infusion, normal saline solution , 1000 cc 1,243 969 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 1,421 1,328 $2K
84163 133 133 $2K
93280 259 250 $2K
90620 38 38 $2K
82140 306 284 $2K
77012 208 189 $2K
17003 420 411 $2K
86593 724 690 $2K
82725 189 186 $2K
83835 187 180 $2K
84154 268 260 $2K
36430 12 12 $2K
84270 146 143 $2K
84460 6,892 6,575 $2K
86941 205 177 $2K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 1,621 1,123 $2K
82248 4,742 4,080 $2K
83010 348 287 $2K
73718 12 12 $2K
82525 169 167 $2K
73218 14 13 $2K
87563 69 66 $2K
94727 42 41 $2K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 3,577 3,377 $2K
82465 910 894 $2K
D2335 30 14 $2K
82787 112 109 $2K
82103 221 215 $2K
82085 291 266 $2K
D2332 27 13 $2K
86705 211 205 $1K
C1887 Catheter, guiding (may include infusion/perfusion capability) 541 508 $1K
86341 123 120 $1K
D9110 63 37 $1K
93350 79 78 $1K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 3,491 3,318 $1K
95018 12 12 $1K
95911 12 12 $1K
D7111 18 13 $1K
92133 71 69 $1K
82310 1,254 1,171 $1K
90474 1,972 1,952 $1K
86805 14 14 $1K
G0009 Administration of pneumococcal vaccine 2,584 2,548 $1K
J0897 Injection, denosumab, 1 mg 15 13 $1K
95250 83 80 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 27 27 $1K
J1630 Injection, haloperidol, up to 5 mg 1,021 892 $1K
87640 206 198 $1K
72050 97 96 $1K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 1,511 1,487 $1K
88348 39 39 $1K
84207 64 64 $1K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 17 13 $1K
86317 96 95 $984.13
P9040 Red blood cells, leukocytes reduced, irradiated, each unit 573 477 $980.10
95024 37 37 $972.43
83935 397 361 $959.13
J2370 Injection, phenylephrine hcl, up to 1 ml 2,627 2,442 $957.91
11103 12 12 $937.60
90688 61 61 $916.27
82962 10,201 8,868 $909.95
73200 26 25 $886.15
86664 100 91 $821.89
90678 46 43 $821.64
82542 83 78 $814.25
82731 15 13 $797.04
87505 16 15 $792.05
94761 319 192 $785.50
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 314 294 $759.43
90636 12 12 $744.45
87329 105 102 $739.46
84450 4,116 3,868 $738.97
93926 13 12 $732.47
82270 363 338 $732.12
83695 154 151 $718.11
J0561 Injection, penicillin g benzathine, 100,000 units 17 13 $679.68
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit 561 546 $679.65
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 1,007 848 $646.36
83521 930 888 $642.95
84446 86 81 $630.62
82247 1,093 938 $618.79
11720 15 12 $615.92
84166 68 67 $605.45
90836 253 248 $597.94
88302 54 51 $572.90
80069 2,642 2,414 $569.71
87181 206 196 $563.72
99493 29 29 $559.18
83090 58 53 $551.88
97750 62 55 $538.15
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 863 849 $533.47
G0297 Low dose ct scan (ldct) for lung cancer screening 17 17 $508.32
82985 56 56 $481.25
74220 27 26 $470.86
84080 84 82 $466.34
84466 50 50 $464.94
0053A 14 14 $458.70
82378 50 49 $454.20
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 2,428 2,312 $452.39
84145 2,615 2,199 $438.51
90674 13 13 $435.24
74175 42 39 $432.22
S0028 Injection, famotidine, 20 mg 462 431 $416.82
85347 132 95 $388.09
73000 14 13 $380.35
0034A 15 15 $366.96
84436 142 136 $341.85
85240 26 26 $326.60
J1836 Injection, metronidazole, 10 mg 268 214 $317.78
ATP06 78 69 $315.12
96158 19 12 $312.97
71100 29 25 $312.22
86645 27 26 $295.80
J2765 Injection, metoclopramide hcl, up to 10 mg 5,779 4,939 $290.27
99383 15 13 $289.13
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 407 258 $279.98
82040 1,811 1,725 $279.55
62368 14 12 $278.30
J1920 Injection, labetalol hydrochloride, 5 mg 120 70 $275.06
84295 1,297 1,140 $266.04
93283 12 12 $254.22
82166 18 12 $238.42
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 29 29 $231.88
0013A 12 12 $229.35
82977 887 847 $224.80
86308 58 57 $221.32
99177 128 72 $218.05
84478 940 669 $205.15
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg 114 89 $199.25
87147 50 45 $197.58
72128 26 25 $196.75
86663 29 27 $177.15
84075 890 851 $153.12
73503 48 47 $150.82
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 5,733 5,549 $149.41
82340 52 52 $148.50
90633 3,055 3,024 $139.50
96368 16 12 $134.50
86304 13 12 $132.93
80183 26 25 $130.19
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 1,700 1,540 $118.15
J1040 Injection, methylprednisolone acetate, 80 mg 19 18 $115.16
74019 27 24 $114.10
82180 28 27 $106.67
87299 26 24 $106.29
82131 12 12 $104.34
86709 12 12 $102.70
96040 1,635 1,551 $102.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 118 115 $99.03
80235 40 38 $95.64
93786 31 30 $93.52
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 307 277 $85.06
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 2,478 2,302 $79.19
80201 15 14 $73.57
J1940 Injection, furosemide, up to 20 mg 747 519 $66.01
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml 417 301 $63.79
J1956 Injection, levofloxacin, 250 mg 30 24 $62.14
80156 13 13 $60.12
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination 164 162 $57.26
G0442 Annual alcohol misuse screening, 5 to 15 minutes 49 48 $55.10
99494 15 15 $55.03
J0670 Injection, mepivacaine hydrochloride, per 10 ml 306 291 $48.65
J0330 Injection, succinylcholine chloride, up to 20 mg 752 676 $47.43
J8540 Dexamethasone, oral, 0.25 mg 325 197 $45.76
89060 14 13 $39.12
80158 12 12 $37.24
51701 57 56 $35.97
90713 171 170 $35.37
90710 1,153 1,140 $32.65
86036 476 455 $29.85
87185 14 14 $29.34
36410 326 298 $28.98
85598 13 13 $28.86
84520 1,644 1,474 $26.19
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 652 628 $24.56
95991 17 14 $18.20
86381 154 149 $17.82
G0444 Annual depression screening, 5 to 15 minutes 12 12 $8.32
J0613 Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg 111 93 $6.96
J1171 Injection, hydromorphone, 0.1 mg 135 94 $4.35
90685 301 295 $2.36
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 659 504 $1.59
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 1,747 1,445 $1.47
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 958 915 $0.39
G0010 Administration of hepatitis b vaccine 101 100 $0.09
90749 14 14 $0.05
90698 2,859 2,826 $0.00
J3480 Injection, potassium chloride, per 2 meq 418 303 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 3,449 3,004 $0.00
90744 1,872 1,843 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 222 208 $0.00
82435 552 497 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 474 436 $0.00
L4360 Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise 349 331 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 165 152 $0.00
90680 3,180 3,149 $0.00
D1330 387 247 $0.00
91301 138 125 $0.00
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 159 154 $0.00
J2785 Injection, regadenoson, 0.1 mg 453 432 $0.00
90697 110 109 $0.00
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries 213 205 $0.00
G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 116 113 $0.00
88300 12 12 $0.00
81596 268 264 $0.00
91303 283 229 $0.00
95012 314 304 $0.00
93246 39 38 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 207 188 $0.00
90723 336 335 $0.00
96139 13 13 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 40 28 $0.00
G8981 Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals 96 93 $0.00
89322 25 24 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 12 12 $0.00
87484 14 12 $0.00
J1790 Injection, droperidol, up to 5 mg 68 55 $0.00
J0611 Injection, calcium gluconate (wg critical care), per 10 ml 52 43 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 54 50 $0.00
96132 28 27 $0.00
93788 31 30 $0.00
L1810 Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise 13 13 $0.00
J3411 Injection, thiamine hcl, 100 mg 17 13 $0.00
G8986 Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting 12 12 $0.00
J0461 Injection, atropine sulfate, 0.01 mg 43 35 $0.00
81370 13 13 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 14 12 $0.00
D2750 19 12 $0.00
88331 14 14 $0.00
C1819 Surgical tissue localization and excision device (implantable) 13 13 $0.00
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens 18 18 $0.00
95874 13 12 $0.00
90648 1,518 1,505 $0.00
L3908 Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf 789 583 $0.00
C1758 Catheter, ureteral 40 38 $0.00
L0626 Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise 284 268 $0.00
91300 10,320 8,662 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 1,048 974 $0.00
90700 1,063 1,052 $0.00
A9577 Injection, gadobenate dimeglumine (multihance), per ml 27 27 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 1,152 1,059 $0.00
80348 478 345 $0.00
86015 139 136 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 309 294 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 7,160 5,986 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 363 278 $0.00
80361 403 313 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 199 131 $0.00
Q9956 Injection, octafluoropropane microspheres, per ml 767 736 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 283 273 $0.00
91312 867 847 $0.00
90672 76 76 $0.00
C1729 Catheter, drainage 214 187 $0.00
96133 28 27 $0.00
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography 105 101 $0.00
C9113 Injection, pantoprazole sodium, per vial 306 188 $0.00
80346 480 347 $0.00
L1820 Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise 16 13 $0.00
78434 120 116 $0.00
80362 403 313 $0.00
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 92 91 $0.00
D0160 16 14 $0.00
84155 29 27 $0.00
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 24 24 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 62 56 $0.00
80365 478 345 $0.00
G8989 Self care functional limitation, discharge status, at discharge from therapy or to end reporting 13 12 $0.00
96136 12 12 $0.00
0121A 16 16 $0.00
Q0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg 18 16 $0.00
A9526 Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries 12 12 $0.00
11101 12 12 $0.00
C1788 Port, indwelling (implantable) 12 12 $0.00
96138 13 13 $0.00
86008 12 12 $0.00